Mechanisms and Therapy of Osmotic Demyelination

2006/07/01 by Takashi Murase, Yoshihisa Sugimura, Seiko Takefuji +2 · 78 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Biomedical and Chemical Research #Blood–brain barrier #Central nervous system #Central pontine myelinolysis #Dexamethasone #Electrolyte and hormonal disorders #Endocrinology #Endogeny #Evans Blue #Extravasation #Hyponatremia #Internal medicine #Ion Transport and Channel Regulation #Medicine #Pathogenesis #Pathology

paper · doi:10.1016/j.amjmed.2006.05.010

published in The American Journal of Medicine 119(7), S69-S73 (Elsevier BV)

openalex publication_date 2006/07/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Hyponatremia in Psychiatric Patients: Update on Evaluation and Management
• Minocycline protects against neurologic complications of rapid correction of hyponatremia. [europepmc]
• Astrocytes are an early target in osmotic demyelination syndrome. [europepmc]
• Osmotic Stress-Induced Defective Glial Proteostasis Contributes to Brain Demyelination after Hyponatremia Treatment. [europepmc]
• Favorable Outcomes Following the Use of Triple Therapy in a Patient with Osmotic Demyelination Syndrome. [europepmc]
• A highly unusual case of osmotic demyelination syndrome and extrapontine myelinolysis in a 3-month-old infant with Bartter syndrome. [europepmc]
• Central pontine myelinolysis during treatment of hyperglycemic hyperosmolar syndrome: a case report. [europepmc]
• Pediatric osmotic demyelination syndrome in a case of type 1 diabetes mellitus with diabetic ketoacidosis. [europepmc]
• Central pontine myelinolysis: a rare finding in hyperosmolar hyperglycemia. [europepmc]